Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson’s disease
Elena Ferrari(University of Milan), Fabrizio Gardoni(University of Milan)
Cited by 27
Related Papers
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
|Progress in Neurobiology|2015|472
Rabphilin 3A retains NMDA receptors at synaptic sites through interaction with GluN2A/PSD-95 complex
|Nature Communications|2015|75